细胞因子信号转导抑制因子3(SOCS3)等多因子检测试剂盒(流式荧光发光法)
Multiplex Assay Kit for Suppressors Of Cytokine Signaling 3 (SOCS3) ,etc. by FLIA (Flow Luminescence Immunoassay)
ATOD4; CIS3; Cish3; MGC71791; SOCS-3; SSI-3; SSI3; Cytokine-inducible SH2 protein 3; STAT-induced STAT inhibitor 3
(注:单次混测多因子不超过8个指标 )
- 编号ULMB684Hu
 - 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
 - 实验方法双抗夹心
 - 反应时长3.5h
 - 检测范围0.98-1000pg/mL
 - 灵敏度最小可检测剂量小于等于0.327 pg/mL.
 - 样本类型Serum, plasma, tissue homogenates, cell lysates, cell culture supernates and other biological fluids
 - 下载 英文说明书 中文说明书
 - 规格 8指标数 7指标数 6指标数 5指标数 4指标数 3指标数 2指标数1指标数
 - 价格 ¥ 1245 ¥ 1293 ¥ 1365 ¥ 1460 ¥ 1556 ¥ 1700 ¥ 1915 ¥ 2394 添加到价格计算器 计算器
 - 欲了解实际交易价格和更多情况,请与当地经销商联系!
 
特异性
                        本试剂盒用于检测细胞因子信号转导抑制因子3(SOCS3)等多因子检测试剂盒(流式荧光发光法),经检测与其它相似物质无明显交叉反应。
                        由于受到技术及样本来源的限制,不可能完成对所有相关或相似物质交叉反应检测,因此本试剂盒有可能与未经检测的其它物质有交叉反应。
                    
回收率
分别于定值血清及血浆样本中加入一定量的细胞因子信号转导抑制因子3(SOCS3)等多因子检测试剂盒(流式荧光发光法)(加标样品),重复测定并计算其均值,回收率为测定值与理论值的比率。
| 样本 | 回收率范围(%) | 平均回收率(%) | 
| serum(n=5) | 95-105 | 99 | 
| EDTA plasma(n=5) | 97-104 | 101 | 
| heparin plasma(n=5) | 88-98 | 93 | 
精密度
                    精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100 
                    批内差:取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次,分别计算不同浓度样本的平均值及SD值。
                    批间差:选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定,每个样本使用同一试剂盒重复测定8次,分别计算不同浓度样本的平均值及SD值。
                    批内差: CV<10% 
                    批间差: CV<12% 
                
线性
在定值血清及血浆样本内加入适量的细胞因子信号转导抑制因子3(SOCS3)等多因子检测试剂盒(流式荧光发光法),并倍比稀释成1:2,1:4,1:8,1:16的待测样本,线性范围即为稀释后样本中细胞因子信号转导抑制因子3(SOCS3)等多因子检测试剂盒(流式荧光发光法)含量的测定值与理论值的比率。
| 样本 | 1:2 | 1:4 | 1:8 | 1:16 | 
| serum(n=5) | 88-102% | 78-104% | 78-101% | 81-97% | 
| EDTA plasma(n=5) | 96-105% | 78-96% | 93-102% | 89-105% | 
| heparin plasma(n=5) | 81-99% | 94-102% | 82-91% | 78-92% | 
稳定性
                    经测定,试剂盒在有效期内按推荐温度保存,其活性降低率小于5%。
                    为减小外部因素对试剂盒破坏前后检测值的影响,实验室的环境条件需尽量保持一致,尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。
                
实验流程
                    1. 实验前标准品、试剂及样本准备;
                            2. 加样(标准品、样本、磁珠)标准品或样本100μL及磁珠10μL,
                                37°C酶标板振荡器孵育90分钟;
                            3. 磁吸甩干,加检测溶液A100μL,37°C酶标板振荡器孵育60分钟;
                            4. 磁吸洗板3次;
                            5. 加检测溶液B100μL,37°C振动孵育30分钟;
                            6. 磁吸洗板3次;
                            7. 加鞘液100μL,旋涡震荡2分钟后读数。
                
实验原理
将细胞因子信号转导抑制因子3(SOCS3)等多因子检测试剂盒(流式荧光发光法)抗体包被于磁珠,制成固相载体,向微孔中分别加入标准品或标本以及磁珠,其中的细胞因子信号转导抑制因子3(SOCS3)等多因子检测试剂盒(流式荧光发光法)与连接于固相载体上的抗体结合,然后加入生物素化的细胞因子信号转导抑制因子3(SOCS3)等多因子检测试剂盒(流式荧光发光法)抗体,将未结合的生物素化抗体洗净后,加入PE标记的亲和素,再次彻底洗涤后即可上机读数。MFI值和样品中的细胞因子信号转导抑制因子3(SOCS3)等多因子检测试剂盒(流式荧光发光法)呈正相关。
赠品
增值服务
相关产品
| 编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) | 
| URPB684Hu01 | 细胞因子信号转导抑制因子3(SOCS3)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. | 
| UPAB684Hu01 | 细胞因子信号转导抑制因子3(SOCS3)多克隆抗体 | WB | 
| UMAB684Hu22 | 细胞因子信号转导抑制因子3(SOCS3)单克隆抗体 | WB; IHC; ICC; IP. | 
| UMEB684Hu | 细胞因子信号转导抑制因子3(SOCS3)检测试剂盒(酶联免疫吸附试验法,小样本) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| USEB684Hu | 细胞因子信号转导抑制因子3(SOCS3)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. | 
| ULMB684Hu | 细胞因子信号转导抑制因子3(SOCS3)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. | 
参考文献
| 杂志 | 参考文献 | 
| The Journal of Biological Chemistry | Human primary keratinocytes show a restricted ability to up-regulate suppressor of cytokine signaling (SOCS)3 compared to autologous macrophages [Jcb: 280370] | 
| The Journal of Biological Chemistry | Human Primary Keratinocytes Show Restricted Ability to Up-regulate Suppressor of Cytokine Signaling (SOCS)3 Protein Compared with Autologous Macrophages [PubMed: PMC3323061] | 
| Journal of Reproductive Immunology | What is the impact of Th1/Th2 ratio, SOCS3, IL17, and IL35 levels in unexplained infertility? [Pubmed: 24368037] | 
| The Journal of Immunology | Alveolar Epithelial Cell–Derived Prostaglandin E2 Serves as a Request Signal for Macrophage Secretion of Suppressor of Cytokine Signaling 3 during Innate Inflammation [Pubmed:27183597] | 
| Scientific Reports | The FXR Agonist, Obeticholic Acid, Suppresses HCC Proliferation & Metastasis: Role of IL-6/STAT3 Signalling Pathway [pubmed:28970500] | 
| Journal of Immunological Methods | Endogenous peroxidases in sputum interfere with horse-radish peroxidase-based ELISAs. [pubmed:29154772] | 
| Turkish Journal Of Medical Sciences | The impact of plasma SOCS3 levels and endometrial leukocytes on unexplained infertility [Pubmed:29914245] | 
| Novel trajectories of Bromocriptine antidiabetic action: Leptin-IL-6/JAK2/p-STAT3/SOCS3, p-IR/p-AKT/GLUT4, PPARγ/Adiponectin, Nrf2/PARP-1, and GLP-1 [articles:10.3389] | |
| JCI Insight | Alveolar macrophage secretion of vesicular SOCS3 represents a platform for lung cancer therapeutics [Pubmed: 31619584] | 
| European Journal of Pharmacology | Olmesartan attenuates type 2 diabetes-associated liver injury: Cross-talk of AGE/RAGE/JNK, STAT3/SCOS3 and RAS signaling pathways [Pubmed: 32067934] | 
| FASEB JOURNAL | Resident alveolar macrophage‐derived vesicular SOCS3 dampens allergic airway inflammation [Pubmed: 32030817] | 
| molecular immunology | SOCS3-deficient lung epithelial cells uptaking neutrophil-derived SOCS3 worsens lung influenza infection [Pubmed: 32645550] | 
| Experimental and Therapeutic Medicine | Changes and clinical significance of serum inflammatory factors in the treatment of pregnancy hypertension syndrome with magnesium sulfate combined with … [Pubmed: 32742411] | 
| NEUROCHEMICAL RESEARCH | Modulation of the Nitric Oxide/BH4 Pathway Protects Against Irradiation-Induced Neuronal Damage [33755856] | 
| BIOMEDICINE & PHARMACOTHERAPY | Potential contribution of ELISA and LFI Assays to assessment of the oxidative stress condition based on 8-oxodG biomarker [33957564] | 

                    
                    
                    